These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 16012716)
21. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival. Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444 [TBL] [Abstract][Full Text] [Related]
28. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas. Shi YZ; Hui AM; Takayama T; Li X; Cui X; Makuuchi M Br J Cancer; 2000 Jul; 83(1):50-5. PubMed ID: 10883667 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405 [TBL] [Abstract][Full Text] [Related]
31. p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer. Ahrendt SA; Brown HM; Komorowski RA; Zhu YR; Wilson SD; Erickson BA; Ritch PS; Pitt HA; Demeure MJ Surgery; 2000 Oct; 128(4):520-30. PubMed ID: 11015084 [TBL] [Abstract][Full Text] [Related]
32. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
33. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression. Kralj M; Husnjak K; Körbler T; Pavelić J Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191 [TBL] [Abstract][Full Text] [Related]
34. Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer. Shimoyama S; Konishi T; Kawahara M; Aoki F; Harada N; Shimizu S; Murakami T; Kaminishi M Hepatogastroenterology; 1998; 45(23):1497-504. PubMed ID: 9840093 [TBL] [Abstract][Full Text] [Related]
35. Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms. Giordano G; Azzoni C; D'Adda T; Rocco A; Gnetti L; Froio E; Merisio C; Melpignano M Pathol Res Pract; 2008; 204(3):163-74. PubMed ID: 18180113 [TBL] [Abstract][Full Text] [Related]
36. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection. Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120 [TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056 [TBL] [Abstract][Full Text] [Related]
38. Quantification of p53 in epithelial ovarian cancer. Geisler JP; Geisler HE; Wiemann MC; Givens SS; Zhou Z; Miller GA Gynecol Oncol; 1997 Sep; 66(3):435-8. PubMed ID: 9299258 [TBL] [Abstract][Full Text] [Related]
39. [Expression of key cell cycle markers in squamous cell carcinoma of the cervix positive in human papillomavirus: a comparative study between Chinese and Australian populations]. Liu JH; Huang H; Huang X; Zeng MS; Li W Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(5):312-6. PubMed ID: 16677523 [TBL] [Abstract][Full Text] [Related]
40. p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival. Karjalainen JM; Eskelinen MJ; Kellokoski JK; Reinikainen M; Alhava EM; Kosma VM Br J Cancer; 1999 Feb; 79(5-6):895-902. PubMed ID: 10070887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]